Brainstorm Cell Therapeut... (BCLI)
NASDAQ: BCLI
· Real-Time Price · USD
1.33
0.17 (14.66%)
At close: May 16, 2025, 3:59 PM
1.26
-5.62%
After-hours: May 16, 2025, 04:40 PM EDT
Brainstorm Cell Therapeutics Revenue
Brainstorm Cell Therapeutics reported an annual revenue of $849K, reflecting a 0% growth. For the quarter ending December 31, 2024, Brainstorm Cell Therapeutics generated $0 in revenue.
Revenue (ttm)
$849K
Revenue Growth
0%
Price / Sales Ratio
14.2
Revenue / Employee
$31.44K
Employees
27
Market Cap
9.68M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|